The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19. 2006

Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
Department of Endocrinology, Neurocrine Biosciences, San Diego, CA 92130, USA.

CC chemokine receptor 7 (CCR7), which regulates the trafficking of leucocytes to the secondary lymphoid organs, has two endogenous chemokine ligands: CCL19 and CCL21. Although both ligands possess similar affinities for the receptor and similar abilities to promote G protein activation and chemotaxis, they share only 25% sequence identity. Here, we show that substituting N-terminal six amino acids of CCL21 (SDGGAQ) for the corresponding N-terminal domain of CCL19 (GTNDAE) results in a chimeric chemokine that exhibits high affinity binding and G protein activation of CCR7. These data demonstrate that despite dissimilar sequences, the amino terminal hexapeptide of these two chemokines is capable of performing similar roles resulting in receptor activation.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016466 CHO Cells CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. CHO Cell,Cell, CHO,Cells, CHO

Related Publications

Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
September 2016, Biochemical and biophysical research communications,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
October 2002, Chemistry & biology,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
August 2018, Journal of leukocyte biology,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
April 2012, Biochemical and biophysical research communications,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
February 2002, Biological & pharmaceutical bulletin,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
October 2001, The Journal of clinical endocrinology and metabolism,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
April 2002, Molecular cell,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
November 2020, The Journal of experimental medicine,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
March 2000, Neuron,
Thomas R Ott, and Francisco M Lio, and Dennis Olshefski, and Xin-Jun Liu, and Nicholas Ling, and R Scott Struthers
May 1993, The Journal of biological chemistry,
Copied contents to your clipboard!